10,000 results
·
193ms
·
Sources: EU EUDAMED, US FDA
CDX2 (QR045)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CDX2 (QR045)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD99 (QR067)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
CD8 (QR068)
Device
EU IVDD
·
Eu Ivd General
·biocyc Biotechnologie GmbH & Co. KG·On the market
Q Mount Permanent (w/o Xylene, Toluol)
Device
EU IVDR
·
Eu Ivd Class A
·biocyc Biotechnologie GmbH & Co. KG·On the market
Q Mount Permanent (w/o Xylene, Toluol)
Device
EU IVDR
·
Eu Ivd Class A
·biocyc Biotechnologie GmbH & Co. KG·On the market
Q Mount Permanent (w/o Xylene, Toluol)
Device
EU IVDR
·
Eu Ivd Class A
·biocyc Biotechnologie GmbH & Co. KG·On the market
Q Mount Permanent (w/o Xylene, Toluol)
Device
EU IVDR
·
Eu Ivd Class A
·biocyc Biotechnologie GmbH & Co. KG·On the market
Q Dewax Solution
Device
EU IVDR
·
Eu Ivd Class A
·biocyc Biotechnologie GmbH & Co. KG·On the market